Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia

Acute lymphoblastic leukemia (ALL) is currently treated with an intense regimen of chemotherapy yielding cure rates near 80%. However, additional changes using available drugs are unlikely to provide significant improvement in survival. New therapies are warranted given the risk of severe therapy-as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Linger, Rachel M. A., DeRyckere, Deborah, Brandão, Luis, Sawczyn, Kelly K., Jacobsen, Kristen M., Liang, Xiayuan, Keating, Amy K., Graham, Douglas K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2927045/
https://ncbi.nlm.nih.gov/pubmed/19643988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-03-209247
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados